ClinicalTrials.gov record
A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.
ClinicalTrials.gov ID: NCT01727141
Public ClinicalTrials.gov record NCT01727141. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.
Study identification
- NCT ID
- NCT01727141
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 1,042 participants
Conditions and interventions
Conditions
Interventions
- QVA149 Drug
- QAB149 Drug
- NVA237 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2012
- Primary completion
- Jan 31, 2014
- Completion
- Jan 31, 2014
- Last update posted
- Mar 28, 2016
2012 – 2014
United States locations
- U.S. sites
- 73
- U.S. states
- 29
- U.S. cities
- 63
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Birmingham | Alabama | 35205 | — |
| Novartis Investigative Site | Montgomery | Alabama | 36109 | — |
| Novartis Investigative Site | Mesa | Arizona | 85205 | — |
| Novartis Investigative Site | Phoenix | Arizona | 85018 | — |
| Novartis Investigative Site | Fountain Valley | California | 92708 | — |
| Novartis Investigative Site | Fullerton | California | 92835 | — |
| Novartis Investigative Site | Huntington Beach | California | 92647 | — |
| Novartis Investigative Site | Montclair | California | 91763 | — |
| Novartis Investigative Site | Orange | California | 92868 | — |
| Novartis Investigative Site | Orangevale | California | 95662 | — |
| Novartis Investigative Site | Paramount | California | 90723 | — |
| Novartis Investigative Site | Riverside | California | 92506 | — |
| Novartis Investigative Site | Roseville | California | 95661 | — |
| Novartis Investigative Site | Sacramento | California | 95817 | — |
| Novartis Investigative Site | Sacramento | California | 95823 | — |
| Novartis Investigative Site | Sacramento | California | 95825 | — |
| Novartis Investigative Site | San Diego | California | 92117-4946 | — |
| Novartis Investigative Site | Torrance | California | 90502 | — |
| Novartis Investigative Site | Wheat Ridge | Colorado | 80033 | — |
| Novartis Investigative Site | Waterbury | Connecticut | 06708 | — |
| Novartis Investigative Site | Chiefland | Florida | 32626 | — |
| Novartis Investigative Site | Clearwater | Florida | 33765 | — |
| Novartis Investigative Site | Lynn Haven | Florida | 32444 | — |
| Novartis Investigative Site | Savannah | Georgia | 31406 | — |
| Novartis Investigative Site | Meridian | Idaho | 83642 | — |
| Novartis Investigative Site | O'Fallon | Illinois | 62269 | — |
| Novartis Investigative Site | River Forest | Illinois | 60305 | — |
| Novartis Investigative Site | Indianapolis | Indiana | 46256 | — |
| Novartis Investigative Site | Columbia | Maryland | 21044 | — |
| Novartis Investigative Site | Waltham | Massachusetts | 02154 | — |
| Novartis Investigative Site | Ann Arbor | Michigan | 48106-0525 | — |
| Novartis Investigative Site | Edina | Minnesota | 55435 | — |
| Novartis Investigative Site | Fridley | Minnesota | 55432 | — |
| Novartis Investigative Site | Minneapolis | Minnesota | 55407 | — |
| Novartis Investigative Site | Rochester | Minnesota | 55901 | — |
| Novartis Investigative Site | Biloxi | Mississippi | 39531 | — |
| Novartis Investigative Site | Saint Charles | Missouri | 63301 | — |
| Novartis Investigative Site | St Louis | Missouri | 63141 | — |
| Novartis Investigative Site | Omaha | Nebraska | 68134 | — |
| Novartis Investigative Site | Papillion | Nebraska | 68046 | — |
| Novartis Investigative Site | Las Vegas | Nevada | 89119 | — |
| Novartis Investigative Site | Brooklyn | New York | 11229 | — |
| Novartis Investigative Site | Brooklyn | New York | 11234 | — |
| Novartis Investigative Site | Great Neck | New York | 11021 | — |
| Novartis Investigative Site | Hendersonville | North Carolina | 28739 | — |
| Novartis Investigative Site | Cincinnati | Ohio | 45242 | — |
| Novartis Investigative Site | Cincinnati | Ohio | 45245 | — |
| Novartis Investigative Site | Columbus | Ohio | 43213 | — |
| Novartis Investigative Site | Columbus | Ohio | 43215 | — |
| Novartis Investigative Site | Dublin | Ohio | 43016 | — |
| Novartis Investigative Site | Marion | Ohio | 43302 | — |
| Novartis Investigative Site | Medford | Oregon | 97504-8741 | — |
| Novartis Investigative Site | Pittsburgh | Pennsylvania | 15213 | — |
| Novartis Investigative Site | Pittsburgh | Pennsylvania | 15221 | — |
| Novartis Investigative Site | Pittsburgh | Pennsylvania | 15236 | — |
| Novartis Investigative Site | Pittsburgh | Pennsylvania | 15243 | — |
| Novartis Investigative Site | Tipton | Pennsylvania | 16684 | — |
| Novartis Investigative Site | Anderson | South Carolina | 29621 | — |
| Novartis Investigative Site | Greenville | South Carolina | 29615 | — |
| Novartis Investigative Site | Spartanburg | South Carolina | 29303 | — |
| Novartis Investigative Site | Union | South Carolina | 29379 | — |
| Novartis Investigative Site | Chattanooga | Tennessee | 37404 | — |
| Novartis Investigative Site | Boerne | Texas | 78006 | — |
| Novartis Investigative Site | Dallas | Texas | 75231-4307 | — |
| Novartis Investigative Site | Dallas | Texas | 75231 | — |
| Novartis Investigative Site | El Paso | Texas | 79902 | — |
| Novartis Investigative Site | San Antonio | Texas | 78205 | — |
| Novartis Investigative Site | South Burlington | Vermont | 05403 | — |
| Novartis Investigative Site | Newport News | Virginia | 23606 | — |
| Novartis Investigative Site | Richmond | Virginia | 23229 | — |
| Novartis Investigative Site | Richmond | Virginia | 23294 | — |
| Novartis Investigative Site | Seattle | Washington | — | — |
| Novartis Investigative Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01727141, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 28, 2016 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01727141 live on ClinicalTrials.gov.